Labeling: pharmacy and manufacturer labels, OTC labels, Medication Guides, patient package inserts
3 free Uniform MPJE practice questions on this topic, with the answer, a reason for every option and the source. The full bank has 35 questions here.
A community pharmacist dispenses oxycodone hydrochloride tablets, a Schedule II controlled substance, to an outpatient. Under federal law, which warning must appear on the prescription label?
- A"Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed."
- B"Caution: Federal law prohibits dispensing without prescription."
- C"Caution: This medication may not be shared, sold or given to any other person without a new prescription from the prescriber."
Show answer and sources
Answer: A. "Caution: Federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed."
The label of any Schedule II, III or IV controlled substance dispensed to or for a patient must carry the federal transfer warning (21 CFR 290.5).
- A. Correct: this is the exact transfer warning that 21 CFR 290.5 requires on dispensed Schedule II–IV labels.
- B. Wrong: this is the old manufacturer legend that the 'Rx only' symbol replaced in 1997; it is not the transfer warning.
- C. Wrong: this is invented wording; 21 CFR 290.5 prescribes specific text about transfer to another person.
- [1] 21 CFR Part 290 — Controlled drugs (FDA) . § 290.5
- [2] 21 U.S.C. §353 — Prescription drugs, samples (503) . 21 U.S.C. 353(b)(4)(A)
Which statement about the federal controlled substance transfer warning is accurate?
- AFDA regulations require the warning on Schedule II labels only.
- BFDA regulations set out an official Spanish-language version of the warning.
- CFDA regulations allow each pharmacy to write its own wording for the warning as long as it keeps the meaning.
Show answer and sources
Answer: B. FDA regulations set out an official Spanish-language version of the warning.
21 CFR 290.6 sets out the official Spanish-language version of the transfer warning required by 21 CFR 290.5, which applies to Schedules II–IV.
- A. Wrong: 21 CFR 290.5 applies to Schedules II, III and IV, not only Schedule II.
- B. Correct: 21 CFR 290.6 gives the Spanish text of the warning.
- C. Wrong: the regulation prescribes the exact wording of the warning.
- [1] 21 CFR Part 290 — Controlled drugs (FDA) . § 290.6; § 290.5
A retail pharmacy sends a Schedule II oxycodone prescription to a central fill pharmacy, which fills it and ships it back for patient pickup. The central fill pharmacy's label must show:
- Athe central fill pharmacy's name and address in place of the retail pharmacy's name and address
- Bthe retail pharmacy's DEA number in place of the retail pharmacy's address
- Cthe retail pharmacy's name and address and the central fill pharmacy's DEA number
Show answer and sources
Answer: C. the retail pharmacy's name and address and the central fill pharmacy's DEA number
When a controlled substance is filled at a central fill pharmacy, the label must show the retail pharmacy's name and address and a unique identifier, the central fill pharmacy's DEA number (21 CFR 1306.14(b)).
- A. Wrong: the retail pharmacy's name and address must appear; the central fill pharmacy is identified by its DEA number.
- B. Wrong: the unique identifier is the central fill pharmacy's DEA number, and the retail pharmacy's address is still required.
- C. Correct: 21 CFR 1306.14(b) requires the retail pharmacy's name and address plus the central fill pharmacy's DEA number.
- [1] 21 CFR Part 1306 — DEA prescriptions . § 1306.14(b); § 1306.24(b)
Practise all 35 questions on this topic
Tutor mode, timed blocks and progress tracking.